comparemela.com

Samuel Brodovsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)

Glaukos (NYSE:GKOS) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. .

Joanne wuenschAllen gongSamuel brodovskyThomas stephanRyan zimmermanDavid saxonAnthony petroneMichael sarconeLarry biegelsenGlaukos corpWells fargoAnalyst firmHealth careJp morganAnalyst ratingsStent inject

Glaukos : Q1 2024 Earnings Transcript - MarketScreener

Corrected Transcript 01-May-2024 Glaukos Corp. Q1 2024 Earnings Call .

United statesAlex thurmanSteven lichtmanMatthew obrienRyan zimmermanDavid saxonThomas william burnsTom stephanMargaret kaczor andrewChris lewisSamuel brodovskyJosephe gilliamPiper sandlerJoe gilliamDimitri tahalLarry biegelsen

10 surgical robotics companies you need to know

The surgical robotics industry saw a major shakeup last year. Here is MassDevice's roundup of companies to watch.

United statesSan carlosLithuania generalCleveland clinicUnited kingdomJian zhangMountain viewAdam sachsBrandy clarkZimmer biometSiemens healthineersJj depuy synthesHani abouhalkaGeoff marthaRyan zimmermanSam durno

Nevro announces layoffs

Pain-treatment device company Nevro is letting go of 63 employees, about 5% of its workforce, as part of a restructuring effort.

United statesRedwood cityTruist richard newitterMassdevice medtechKevin thornalSamuel brodovskyLin zhangVyrsa technologiesRichard newitter

iRhythm releases strong Q4 prelims, strengthens balance sheet

today released a solid preliminary earnings update that included projections of up to 20% revenue growth in 2024.

Samuel brodovskyMassdevice medtechQuentin blackfordRichard newitterRhythm technologiesHealthcare conferenceLin zhang

vimarsana © 2020. All Rights Reserved.